Fragasso Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.98M Buy
21,424
+291
+1% +$54K 0.27% 40
2025
Q1
$4.43M Buy
21,133
+8,361
+65% +$1.75M 0.33% 36
2024
Q4
$2.27M Buy
12,772
+180
+1% +$32K 0.17% 72
2024
Q3
$2.49M Buy
12,592
+409
+3% +$80.8K 0.19% 73
2024
Q2
$2.09M Buy
12,183
+229
+2% +$39.3K 0.17% 75
2024
Q1
$2.18M Sell
11,954
-27
-0.2% -$4.92K 0.18% 75
2023
Q4
$1.86M Sell
11,981
-163
-1% -$25.3K 0.17% 79
2023
Q3
$1.81M Buy
12,144
+179
+1% +$26.7K 0.19% 72
2023
Q2
$1.61M Buy
11,965
+271
+2% +$36.5K 0.17% 86
2023
Q1
$1.86M Buy
11,694
+32
+0.3% +$5.1K 0.21% 61
2022
Q4
$1.88M Buy
11,662
+30
+0.3% +$4.85K 0.22% 63
2022
Q3
$1.56M Buy
11,632
+56
+0.5% +$7.52K 0.22% 55
2022
Q2
$1.77M Sell
11,576
-49
-0.4% -$7.51K 0.24% 54
2022
Q1
$1.88M Buy
11,625
+154
+1% +$25K 0.22% 53
2021
Q4
$1.55M Sell
11,471
-639
-5% -$86.5K 0.18% 65
2021
Q3
$1.31M Buy
12,110
+645
+6% +$69.6K 0.17% 63
2021
Q2
$1.29M Buy
11,465
+23
+0.2% +$2.59K 0.17% 64
2021
Q1
$1.24M Buy
11,442
+103
+0.9% +$11.1K 0.17% 67
2020
Q4
$1.22M Buy
11,339
+62
+0.5% +$6.64K 0.18% 62
2020
Q3
$988K Buy
11,277
+69
+0.6% +$6.05K 0.16% 62
2020
Q2
$1.04M Buy
11,208
+4,746
+73% +$441K 0.18% 64
2020
Q1
$492K Hold
6,462
0.11% 80
2019
Q4
$572K Buy
6,462
+135
+2% +$12K 0.1% 91
2019
Q3
$479K Buy
6,327
+62
+1% +$4.69K 0.09% 90
2019
Q2
$456K Buy
6,265
+70
+1% +$5.1K 0.09% 92
2019
Q1
$499K Buy
6,195
+70
+1% +$5.64K 0.11% 79
2018
Q4
$565K Sell
6,125
-7
-0.1% -$646 0.13% 91
2018
Q3
$549K Buy
6,132
+475
+8% +$42.5K 0.13% 78
2018
Q2
$524K Hold
5,657
0.14% 74
2018
Q1
$535K Sell
5,657
-74
-1% -$7K 0.13% 74
2017
Q4
$554K Buy
5,731
+113
+2% +$10.9K 0.13% 74
2017
Q3
$499K Buy
+5,618
New +$499K 0.15% 74
2014
Q4
Sell
-5,183
Closed -$299K 46
2014
Q3
$299K Buy
5,183
+115
+2% +$6.64K 0.23% 65
2014
Q2
$286K Sell
5,068
-46
-0.9% -$2.6K 0.25% 60
2014
Q1
$263K Hold
5,114
0.27% 60
2013
Q4
$270K Buy
+5,114
New +$270K 0.24% 57